Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,924 | 81,453 | 24,152 | 12,202 | -896 |
| Depreciation Amortization | 908 | 1,589 | 922 | 556 | 244 |
| Income taxes - deferred | 4,212 | -30,116 | 0 | 0 | 0 |
| Accounts receivable | -42,548 | -15,919 | -20,783 | -25,760 | -259 |
| Accounts payable and accrued liabilities | 4,311 | 10,668 | 7,747 | 7,574 | 6,438 |
| Other Working Capital | -45,126 | -8,694 | -17,838 | -16,208 | 2,482 |
| Other Operating Activity | 42,883 | 14,226 | 19,452 | 22,120 | -4,901 |
| Operating Cash Flow | $-12,436 | $53,207 | $13,652 | $484 | $3,108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -676 | -6,440 | -1,083 | -904 | -804 |
| Net Acquisitions | N/A | -25,110 | -3,100 | -3,100 | -3,100 |
| Purchase Sale Intangibles | N/A | -14,250 | -14,000 | N/A | N/A |
| Other Investing Activity | 0 | -14,250 | -14,000 | 0 | 0 |
| Investing Cash Flow | $-676 | $-45,800 | $-18,183 | $-4,004 | $-3,904 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,137 | 3,619 | 1,486 | 0 | 0 |
| Common Stock Repurchased | -13,653 | -37,003 | -16,497 | 0 | 0 |
| Other Financing Activity | -482 | -286 | -230 | 0 | 0 |
| Financing Cash Flow | $-11,998 | $-33,670 | $-15,241 | $N/A | $N/A |
| Beginning Cash Position | 52,820 | 79,083 | 79,083 | 79,083 | 79,083 |
| End Cash Position | 27,710 | 52,820 | 59,311 | 75,563 | 78,287 |
| Net Cash Flow | $-25,110 | $-26,263 | $-19,772 | $-3,520 | $-796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,436 | 53,207 | 13,652 | 484 | 3,108 |
| Capital Expenditure | -676 | -1,590 | -1,083 | -904 | -804 |
| Free Cash Flow | -13,112 | 51,617 | 12,569 | -420 | 2,304 |